Most cited papers from Sysmex (Germany)

Sysmex (Germany)

What are the most cited papers from Sysmex (Germany)?

The most cited paper from Sysmex (Germany) is "MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression" (Mark Magdi Awad, Geoffrey R. Oxnard, David Michael Jackman et al., 2016), with 706 citations. Next come "Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment" (256) and "Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing" (198).

Published TypeFieldAccessCitations

Showing 50 of 60 papers. Every paper with more than 4 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression Mark Magdi Awad, Geoffrey R. Oxnard, David Michael Jackman et al. · Journal of Clinical Oncology Open access	5 Jan 2016	706
2	Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment Maria Pia Morelli, Michael James Overman, Arvind N. Dasari et al. · Annals of Oncology Open access	28 Jan 2015	256
3	Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing Inga Medina Diaz, Annette Nocon, Daniel H. Mehnert et al. · PLoS ONE Open access	10 Nov 2016	198
4	Reference intervals: the way forward Ferruccio Ceriotti, Rolf Hinzmann, Mauro Panteghini · Annals of Clinical Biochemistry International Journal of Laboratory Medicine	22 Dec 2008	198
5	Repeated mutKRAS ctDNA measurements represent a novel and promising tool for early response prediction and therapy monitoring in advanced pancreatic cancer Stephan Krüger, Volker Heinemann, C. M. D. Ross et al. · Annals of Oncology Open access	19 Sep 2018	164
6	Revisiting the white blood cell count: immature granulocytes count as a diagnostic marker to discriminate between SIRS and sepsis - a prospective, observational study Axel Nierhaus, Stefanie Klatte, Jo Linssen et al. · BMC Immunology Open access	11 Feb 2013	137
7	Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies Filip Jankú et al. · Oncotarget Open access	25 Feb 2015	94
8	Performance evaluation and relevance of the CellaVision TM DM96 system in routine analysis and in patients with malignant hematological diseases Édouard Cornet, J.‐P. PEROL, Xavier Troussard · International Journal of Laboratory Hematology Open access	29 Oct 2008	78
9	A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study Joachim Linssen et al. · eLife Open access	26 Nov 2020	59
10	Detection of TP53 and PIK3CA Mutations in Circulating Tumor DNA Using Next-Generation Sequencing in the Screening Process for Early Breast Cancer Diagnosis Begoña Jiménez Rodríguez, Gema Díaz Córdoba, Alicia Garrido Aranda et al. · Journal of Clinical Medicine Open access	7 Aug 2019	59
11	Identification and quantification of high fluorescence‐stained lymphocytes as antibody synthesizing/secreting cells using the automated routine hematology analyzer XE‐2100 Joachim Linssen, V. Jennissen, Jörg Hildmann et al. · Cytometry Part B Clinical Cytometry	31 Jan 2007	53
12	Pre-Analytical Evaluation of Streck Cell-Free DNA Blood Collection Tubes for Liquid Profiling in Oncology Inga Medina Diaz, Annette Nocon, Stefanie AE Held et al. · Diagnostics Open access	29 Mar 2023	52
13	Reference intervals for Sysmex XN hematological parameters as assessed in the Dutch Lifelines cohort Lucas Joost Van Pelt, Stefanie Klatte, Talent Hwandih et al. · Clinical Chemistry and Laboratory Medicine (CCLM) Open access	30 Apr 2022	48
14	Improved Flagging Rates on the Sysmex XE-5000 Compared With the XE-2100 Reduce the Number of Manual Film Reviews and Increase Laboratory Productivity Carol J. Briggs, Joachim Linssen, Ian Longair et al. · American Journal of Clinical Pathology	14 Jul 2011	48
15	Where is laboratory medicine headed in the next decade? Partnership model for efficient integration and adoption of artificial intelligence into medical laboratories Anna Carobene, Federico Cabitza, Sergio Bernardini et al. · Clinical Chemistry and Laboratory Medicine (CCLM) Open access	3 Nov 2022	39
16	Efficacy of Advanced Discriminating Algorithms for Screening on Iron-Deficiency Anemia and β-Thalassemia Trait Margreet Schoorl, Marianne Schoorl, Jo Linssen et al. · American Journal of Clinical Pathology	Aug 2012	39
17	Automation and validation of a rapid method to assess neutrophil and monocyte activation by routine fluorescence flow cytometry in vitro Jo Linssen, S. Aderhold, Axel Nierhaus et al. · Cytometry Part B Clinical Cytometry Open access	22 Apr 2008	39
18	The 2000HIV study: Design, multi-omics methods and participant characteristics Wilhelm A. J. W. Vos et al. · Frontiers in Immunology Open access	20 Dec 2022	35
19	Bacteriuria and phenotypic antimicrobial susceptibility testing in 45 min by point-of-care Sysmex PA-100 System: first clinical evaluation Carles Alonso-Tarrés, Carla Benjumea Moreno, Ferrán Navarro et al. · European Journal of Clinical Microbiology & Infectious Diseases Open access	3 Jun 2024	32
20	Type 1 inflammatory endotype relates to low compliance, lung fibrosis, and severe complications in COVID-19 Takehiro Hasegawa, Atsushi Nakagawa, Kohjin Suzuki et al. · Cytokine Open access	7 Jun 2021	32
21	An unbiased tissue transcriptome analysis identifies potential markers for skin phenotypes and therapeutic responses in atopic dermatitis Ayano Fukushima‐Nomura, Hiroshi Kawasaki, Kiyoshi Yashiro et al. · Nature Communications Open access	2 Jun 2025	26
22	Evaluation of the Sysmex XT-2000iV haematology analyser for rat, dog and mouse whole blood samples R. A. Mathers, G. O. Evans, John Bleby et al. · Comparative Clinical Pathology	28 Apr 2008	24
23	Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC) Panagiota Economopoulou, Aris Spathis, Ioannis Kotsantis et al. · Oral Oncology	3 Mar 2023	23
24	Quantification of Amyloid-β in Plasma by Simple and Highly Sensitive Immunoaffinity Enrichment and LC-MS/MS Assay Takuya Iino, Shunsuke Watanabe, Kazuto Yamashita et al. · The Journal of Applied Laboratory Medicine Open access	30 Nov 2020	23
25	Profiling of circulating tumor DNA in plasma of non‐small cell lung cancer patients, monitoring of epidermal growth factor receptor p.T790M mutated allelic fraction using beads, emulsion, amplification, and magnetics companion assay and evaluation in future application in mimicking circulating tumor cells Jessica Garcia, Anne‐Sophie Wozny, Florence Geiguer et al. · Cancer Medicine Open access	21 May 2019	19
26	Detection and Quantification of KIT Mutations in ctDNA by Plasma Safe-SeqS Johannes Fredebohm, Daniel H. Mehnert, Ann-Kathrin Löber et al. · Advances in experimental medicine and biology Book chapter	2016	19
27	Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment Ari Joseph Rosenberg, Evgeny Izumchenko, Alexander T. Pearson et al. · BMC Cancer Open access	3 Jan 2022	18
28	Total and differential leucocyte counts in rat and mouse bronchoalveolar lavage fluids using the Sysmex XT-2000iV R. A. Mathers, G. O. Evans, John Bleby et al. · Comparative Clinical Pathology	20 Nov 2006	18
29	Correlates of Neutralizing/SARS-CoV-2-S1-binding Antibody Response with Adverse Effects and Immune Kinetics in BNT162b2-Vaccinated Individuals Kenji Maeda et al. · Research Square PreprintOpen access	3 Sep 2021	16
30	Cyt‐Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2019 Conference Workshops Kamila Czechowska et al. · Cytometry Part A	Dec 2019	16
31	Fragmented red cells reference range for the Sysmex XN ®‐series of automated blood cell counters Jean‐François Lesesve, Élodie Speyer, J.‐P. PEROL · International Journal of Laboratory Hematology	17 Apr 2015	16
32	Stool-Based Testing for Post-Polypectomy Colorectal Cancer Surveillance Safely Reduces Colonoscopies: The MOCCAS Study Beatriz G. Carvalho et al. · Gastroenterology Open access	30 Aug 2024	15
33	Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response Nikaoly Ciriaco, Esther Zamora, Santiago Escrivá-de-Romaní et al. · Therapeutic Advances in Medical Oncology Open access	2022	15
34	Performance of the XN-2000 WPC channel-flagging to differentiate reactive and neoplastic leukocytosis Peter Schuff‐Werner, Peter Kohlschein, Aliaksandra Maroz et al. · Clinical Chemistry and Laboratory Medicine (CCLM)	24 Jan 2016	15
35	Performance evaluation of the new Sysmex XR-Series haematology analyser Kenichi Fujimaki, Kornelia Hummel, Immaculate Magonde et al. · Practical Laboratory Medicine Open access	15 Feb 2024	14
36	A method comparison study of the high throughput automated HISCL® SARS‐CoV‐2 antigen assay using nasopharyngeal swab samples from symptomatic and asymptomatic subjects against conventional RT‐PCR Joachim Linssen, Claire Schapendonk, Marion Münster et al. · Journal of Medical Virology Open access	25 Feb 2022	13
37	Th1 cytokine endotype discriminates and predicts severe complications in COVID-19 Takehiro Hasegawa, Takashi Hato, Toshitsugu Okayama et al. · European Cytokine Network Open access	Jun 2022	12
38	Evaluation of the Sysmex XN ‐31 automated analyser for blood donor malaria screening at Malawi Blood Transfusion Services Bridon M’baya, Thom Mfune, Aubrey Samon et al. · Vox Sanguinis Open access	23 Sep 2021	12
39	Comparison of the cytokine adsorption ability in continuous renal replacement therapy using polyethyleneimine-coated polyacrylonitrile (AN69ST) or polymethylmethacrylate (PMMA) hemofilters: a pilot single-center open-label randomized control trial Yoshihiko Nakamura, Hiroki Hatomoto, Shintaro Yamasaki et al. · European journal of medical research Open access	30 Jun 2023	11
40	The prognostic value of Krebs von den Lungen-6 and surfactant protein-A levels in the patients with interstitial lung disease Peiyan Zheng, Xiaomao Zheng, Hasegawa Takehiro et al. · Journal of Translational Internal Medicine Open access	Sep 2021	11
41	Patient-centric thresholding of Cobas® EGFR mutation Test v2 for surveillance of EGFR-mutated metastatic non-small cell lung cancer Jonas Claus, Dieter De Smet, Joke Breyne et al. · Scientific Reports Open access	6 Aug 2024	10
42	Analytical and clinical performance validation of HPV-SEQ, a novel NGS-based liquid biopsy platform for detection and quantification of human papilloma virus circulating tumor DNA Samaneh Eickelschulte et al. · Oral Oncology Open access	26 Jun 2025	9
43	Broad spectrum of regorafenib activity on mutant KIT and absence of clonal selection in gastrointestinal stromal tumor (GIST): correlative analysis from the GRID trial Michael Jeffers, Christian Kappeler, Iris Kuss et al. · Gastric Cancer Open access	20 Jan 2022	9
44	Routine Molecular Screening of Patients with Advanced Non-SmallCell Lung Cancer in Circulating Cell-Free DNA at Diagnosis and During Progression Using OncoBEAMTM EGFR V2 and NGS Technologies Jessica Garcia, Arnaud Gauthier, Gaëlle Lescuyer et al. · Molecular Diagnosis & Therapy Open access	Mar 2021	9
45	Surveillance of Disease Progression in Metastatic Breast Cancer by Molecular Counting of Circulating Tumor DNA Using Plasma-SeqSensei Breast Cancer in Vitro Diagnostics Assay Geert Antoine Martens, Jan H. Demol, Franceska Dedeurwaerdere et al. · Journal of Molecular Diagnostics Open access	7 Nov 2024	8
46	ExoCounter Assays Identify Women Who May Develop Early-Onset Preeclampsia From 12.5 μL First-Trimester Serum by Characterizing Placental Small Extracellular Vesicles Shuhan Jiang, Wei Zhang, Qing Cao et al. · Hypertension Open access	25 May 2023	8
47	Bone Marrow Cells and Myocardial Regeneration Fu‐Sheng Wang, Cathy Trester · International Journal of Hematology	May 2004	8
48	Development of a new HISCL automated CXCL9 immunoassay Takehiro Hasegawa, Maho Yoshida, Shunsuke Watanabe et al. · Scientific Reports Open access	Apr 2023	7
49	Blood-based RAS mutation testing: concordance with tissue-based RAS testing and mutational changes on progression Theodora Germetaki, Camille Nicholls, Richard Adams et al. · Future Oncology Open access	27 Jul 2020	7
50	Measurement of CD4+ T cells in point‐of‐care settings with the Sysmex pocH‐100i haematological analyser Carol J. Briggs, SJ Machin, M. K. Müller et al. · International Journal of Laboratory Hematology Open access	23 Feb 2009	7

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.